Is a complete SHE/300677 research report available?

Question

Accepted Answer

No complete published report is available for she/300677 (SHE/300677) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Volume
Market cap	32.5B
Revenue (ttm)	10.3B
Net income (ttm)	668M
EPS (ttm)	CN¥1.10
Shares out	647.7M
P/E (trailing)	45.8x
P/E (forward)	13.3x
Dividend	CN¥0.15 (0.33%)

Metric	Value
Country	China
Country code	CN
Employees	12,941
Employees Change	1,959%
Employees Change Percent	17.84
Enterprise value	CNY 37.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Industry PE	38.28
Industry PE Fwd	24.32
Isin	CNE100003456
Last refreshed	2026-07-30
Market cap	CNY 32.5B
Price	CNY 48.58
Price currency	CNY
Rev Per Employee	797,381.98x
Sector	Healthcare
Sector PE	39.23
Sector PE Fwd	22.22
Sic	3842
Symbol	she/300677
Website	https://www.intcomedical.com.cn

Metric	Value
Earnings Yield	2.05%
EV Earnings	56.31x
EV/EBIT	35.95x
EV/EBITDA	18.46x
EV/Sales	3.65x
FCF yield	-1.9%
Forward P/E	13.3x
P/B ratio	1.75x
P/E ratio	45.75x
P/S ratio	3.15x
PE Ratio10 Y	21.05x
PE Ratio3 Y	25.73x
PE Ratio5 Y	20.65x

Metric	Value
EBIT Margin	10.14%
EBITDA Margin	19.73%
Gross margin	24.6%
Gross Profit	CNY 2.5B
Gross Profit Growth	9.23%
Gross Profit Growth Q	27.3%
Gross Profit Growth3 Y	67.41%
Gross Profit Growth5 Y	-28.96%
Net Income	CNY 668M
Net Income Growth	-57.72%
Net Income Growth Q	-97.16%
Net Income Growth Years	0%
Net Income Growth3 Y	19.39%
Net Income Growth5 Y	-42.48%
Pretax Margin	8.52%
Profit Margin	6.47%
Profit Per Employee	CNY 51,620
Profitable Quarters	CNY 12
Profitable Years	13
ROA	1.69
Roa5y	6.94
ROCE	5.03
ROE	3.8
Roe5y	15.86
ROIC	3.59
Roic5y	27.76

Metric	Value
Cagr1y	56.5%
Cagr3y	32.21%
Cagr5y	-2.53%
Div CAGR3	14.47%
Div CAGR5	-40.1%
EPS Growth	-55.32
EPS Growth Q	-96.36
EPS Growth Years	0
EPS Growth3 Y	23.14
EPS Growth5 Y	-41.89
OCF Growth	33.71%
OCF Growth Q	-28.53%
OCF Growth10 Y	37.26%
OCF Growth3 Y	55.1%
OCF Growth5 Y	-31.09%
Revenue Growth	5.14x
Revenue Growth Q	15.76x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	20.49x
Revenue Growth5 Y	-12.22x

SHE/300677 (SHE/300677)

Coverage state: Market snapshot only — no published research

Generate the first SHE/300677 analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SHE/300677

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300677 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SHE/300677

Frequently asked questions

Metric	Value
Asset Turnover	CNY 0.27
Assets	CNY 40.3B
Cash	CNY 12.9B
Current Assets	CNY 16.4B
Current Liabilities	CNY 19.5B
Debt	CNY 17.6B
Debt EBITDA	CNY 8.66
Debt Equity	CNY 0.95
Debt FCF	CNY -28.59
Equity	CNY 18.6B
Interest Coverage	2.83
Liabilities	CNY 21.7B
Long Term Assets	CNY 23.9B
Long Term Liabilities	CNY 2.2B
Net Cash	CNY -4.8B
Net Cash By Market Cap	CNY -14.7
Net Debt EBITDA	CNY 2.35
Net Debt Equity	CNY 0.26
Tangible Book Value	CNY 17.5B
Tangible Book Value Per Share	CNY 34.96
WACC	3.95

Metric	Value
Current ratio	0.84
Inventory Turnover	5.26
Net Working Capital	CNY 1.4B
Quick ratio	0.73
Working Capital	CNY -3.1B
Working Capital Turnover	CNY 4.85

Metric	Value
Buyback Yield	5.37%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	CNY 0.15
Dividend Years	9
Dividend Yield	0.33%
Ex Div Date	2026-06-11
Last Dividend	CNY 0.1
Payout Frequency	Semi-Annual
Payout Ratio	73.96%

Metric	Value
1Y total return	56.45%
200-day SMA	45.46
3Y total return	131.15%
50-day SMA	44.54
50-day SMA vs 200-day SMA	50under200
5Y total return	-12.02%
All Time High	166.7
All Time High Change	-69.88%
All Time High Date	2021-01-25
All Time Low	4.99
All Time Low Change	907.02%
All Time Low Date	2017-07-21
ATR	2.6
Beta	0.17
Beta1y	-0.9
Beta2y	-0.21
Ch YTD	29.05
High	50.7
High52	68.44
High52 Date	2026-04-07
High52ch	-29.02%
Low	45.85
Low52	31.73
Low52 Date	2025-07-29
Low52ch	53.1%
Ma50ch	12.71%
Price vs 200-day SMA	10.43%
RSI	63.26
RSI Monthly	60.79
RSI Weekly	54.62
Sharpe ratio	1.25x
Sortino ratio	2.18
Total Return	5.69%
Tr YTD	29.32
Tr1m	31.04%
Tr1w	6.92%
Tr3m	-12.17%

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Operating Income	CNY 1B
Operating Income Growth	1.7
Operating Income Growth Q	47.58
Operating Income Growth5 Y	-39.43
Operating margin	10.14
Price target	CNY 80
Price Target Change	CNY 64.68

Metric	Value
Float	414,740,061%
Net Borrowing	2,677,283,412
Shares Insiders	35.97%
Shares Institutions	18.38%
Shares Out	647,725,063
Shares Qo Q	-24.29%
Shares Yo Y	-5.37%

Metric	Value
Average Volume	13,630,900.2x
Bv Per Share	36.39
CAPEX	CNY -2.4B
Ch1m	31.04
Ch1w	6.92
Ch1y	55.9
Ch3m	-12.36
Ch3y	128.2
Ch5y	-15.67
Ch6m	18.82
Change	-3.23%
Change From Open	5.95
Close	50.2
Days Gap	-8.67
Depreciation Amortization	989,940,490
Dollar Volume	152,902,732.4
Earnings Date	2026-08-25
EBIT	CNY 1B
EBITDA	CNY 2B
EPS	CNY 1.1
F Score	5
FCF	CNY -617.2M
FCF EV Yield	-1.64x
FCF Per Share	CNY -0.95
Financing CF	6,628,615,755
Fiscal Year End	December
Founded	2,009
Graham Number	29.97211
Graham Upside	-40.29
Income Tax	CNY 182.9M
Investing CF	-9,522,615,142
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2022-06-13
Last Split Type	Forward
Lynch Fair Value	CNY 5.49
Lynch Upside	-89.07
Ma150	47.15
Ma150ch	6.46%
Ma20	45.55
Ma20ch	10.2%
Net CF	-1,521,605,464
Next Earnings Date	2026-08-25
Open	45.85
P OCF Ratio	18.38
Payment Date	2026-06-11
Position In Range	56.29
Ppne	11,609,124,815
Price Date	2026-07-30
Price EBITDA	CNY 15.97
Ptbv Ratio	1.85
Relative Volume	0.23x
Revenue	10,318,920,212x
Tax By Revenue	1.77x
Tax Rate	20.8%
Tr6m	19.07%
Volume	3,147,442
Z Score	1.47